European Business Awards 'Ones to Watch List'

Venture Life Group PLC
(“Venture Life” or the “Company”)

Venture Life Group plc (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, announces it has secured a new long term exclusive distribution deal in Austria with a new partner for its Procto-eze range.

Germania Pharmazeutika GesmbH ("Germania") is a privately owned pharmaceutical company focused on products specifically for women's health, diabetes and gastro related issues. Germania will launch all products in the Procto-eze range in 2018. The range comprises of three products: cleanser, cream and wipes. These provide a comprehensive treatment regimen for haemorrhoids and anal irritation for men and women.

Separately, the Company announces that it has received a patent grant for its UltraDEX Sensitive range in Indonesia. This further strengthens its patent base for UltraDEX Sensitive, as the Company continues its search for international partners. UltraDEX Sensitive will launch next in the Nordic regions in Q1 2018 and final launch plans are in the process of being completed.

Commenting, Chief Executive Officer, Jerry Randall, said: "We're delighted to be considered for these awards. We are consistently recognised as an innovative, fast growing and dynamic business and we are pleased to see that our development and growth over the last couple of years has been seen by others as a good achievement and something to be proud of. The business is going well, and for the year to December 2016 we announced our first EBITDA profit, demonstrating the focused strategy of the Group is working. We expect to see further growth going into 2018 and look forward to more positive announcements this year."

For further information, please contact:

Venture Life Group PLC           +44 (0) 1344 742870
Jerry Randall, Chief Executive Officer
Adrian Crockett, Chief Financial Officer

Northland Capital Partners Limited
(Nominated Adviser and Joint Broker)
            +44 (0) 20 3861 6625
Matthew Johnson / Edward Hutton / Margarita Mitropoulou (Corporate Finance)
Bob Pountney / John Howes (Corporate Broking)

Turner Pope Investments (TPI) Ltd (Joint Broker)            +44 (0) 20 3621 4120
James Pope / Ben Turner

Walbrook PR  or + 44 (0) 20 7933 8780
Paul McManus / Anna Dunphy +44 (0) 7980 541 893 / +44 (0) 7876 741 001

About Venture Life (
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group’s product portfolio includes some key products such as the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, medical devices for women’s intimate healthcare and haemorrhoids and dermo-cosmetics for addressing the signs of ageing.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group’s international distribution partners.
Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.